Sign In
Get Clay Free →

Suggestions

    Nicholas Siciliano

    Chief Executive Officer at Vittoria Biotherapeutics, Inc.

    Nicholas Siciliano is the Chief Executive Officer of Vittoria Biotherapeutics, a cutting-edge gene-edited cell therapy company that holds a unique technology from the University of Pennsylvania.

    Before his current role, Siciliano co-founded and led Invisible Sentinel as CEO from 2013 to 2021, overseeing commercial strategies, research and development, operations, and business growth.

    With a background in immunology, Siciliano leverages over 20 years of expertise in immunology, microbiology, molecular biology, diagnostics, therapeutics, and assay development to foster innovation and advancement.

    Apart from his corporate roles, Siciliano actively engages in educational programs, including lecturing on entrepreneurship at local universities and participating in initiatives like the Drexel University Co-Op Program and Wistar Biomedical Technician Training Program.

    Siciliano also contributes to the field as the President of the Jefferson College of Life Sciences Alumni Board at Thomas Jefferson University.

    His academic journey includes a Ph.D. in Immunology and Microbial Pathogenesis from Thomas Jefferson University and a B.S. in Chemistry and Biochemistry from Villanova University.

    N
    Add to my network

    Location

    Philadelphia, Pennsylvania, United States